
ABB Posts Strong Order Growth on Rising Demand From US
Second-quarter orders rose 16% to $9.79 billion, the Zurich-based industrial firm said Thursday in a statement, above the $8.93 billion average estimate of analysts polled by Bloomberg. The margin on earnings before interest, taxes and amortization came in at 19.2%, versus the 18.8% estimate.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
15 minutes ago
- Yahoo
HIMS: Hims & Hers Shares Sink After FTC Probe Details Emerge
Aug 15 - Hims & Hers Health (NYSE:HIMS) slipped about 3% in early trading on Friday after Bloomberg published fresh details about a Federal Trade Commission probe into the company's business practices. The report says the FTC opened an inquiry following consumer complaints that Hims & Hers makes it hard for customers to cancel subscriptions and questions the company's advertising practices. Warning! GuruFocus has detected 4 Warning Sign with HIMS. Hims & Hers first told investors about a regulatory review in July 2024, but Bloomberg's report adds new color on what regulators are investigating. According to people familiar with the matter, the agency looks at cancellation flows, disclosure language, and whether marketing crosses legal lines. The company hasn't released a new statement tied to the Bloomberg story. For investors, the short-term hit reflects the subscription model's vulnerability: when regulators probe cancellation or billing, churn can rise and trust can fall. Analysts will watch complaint volumes, any formal FTC subpoenas, and whether the firm needs to change its renewal mechanics or face penalties. Until that clarity arrives, expect volatility around HIMS shares as traders price regulatory risk into the stock. Based on the one year price targets offered by 13 analysts, the average target price for Hims & Hers Health Inc is $51.22 with a high estimate of $85.00 and a low estimate of $28.00. The average target implies a upside of +8.67% from the current price of $47.13. Based on GuruFocus estimates, the estimated GF Value for Hims & Hers Health Inc in one year is $36.25, suggesting a downside of -23.09% from the current price of $47.13. Gf value is Gurufocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. For deeper insights, visit the forecast page. This article first appeared on GuruFocus.
Yahoo
15 minutes ago
- Yahoo
Former Liverpool Star Heaps Praise on ‘Tremendous' Michael Edwards
Liverpool Transfer Masterclass Leaves Danny Murphy Full of Praise for Michael Edwards Liverpool's summer business has once again caught the eye, not just for the players brought in but for the impressive sums raised through sales. Michael Edwards, working alongside Richard Hughes, has overseen a series of high-value departures that have left the club in a strong financial position. Liverpool's Profitable Player Exits This summer has seen the departures of several key figures. Darwin Nunez and Luis Diaz, both influential last season, moved on after campaigns that did not fully hit the heights expected. Caoimhin Kelleher and Jarell Quansah have also been sold, contributing further to the club's growing transfer fund. With a couple of weeks still remaining in the transfer window, Arne Slot has room to add more new faces should he see fit. Having already delivered Liverpool the Premier League title in his first season, Slot now has the opportunity to refresh the squad while keeping the club's financial footing secure. Photo: IMAGO Danny Murphy Impressed by Diaz Transfer Fee One deal in particular has drawn admiration from former Liverpool midfielder Danny Murphy. The sale of Luis Diaz to a European rival brought in around £65.5 million, despite the Colombian having only two years left on his contract. Murphy did not hold back in his praise for Edwards. 'I think Michael Edwards and Richard Hughes have done a sterling job in that respect [the fees they've got for their sales],' he said. 'If you're good at what you do, then the players you then need to move on or sell on are always going to have good value. 'The money they got for Diaz is tremendous, really, when you think about it, he wouldn't sign a new deal, he's a quality player, people want him. And that gives you the capability to then do what they're doing now, so it's positive, I don't see any negatives with what's going on at all.' Michael Edwards' Proven Strategy at Liverpool Liverpool's ability to maximise transfer fees has been a defining feature of their recruitment policy over recent years. While not every departure has brought in a windfall, the success rate remains high. The club's approach of acquiring players at reasonable prices and selling them at their peak value has kept their net spend low, ensuring they remain competitive without overspending. Even after several high-profile exits, there is still talent in reserve. Harvey Elliott, Ben Doak and Kostas Tsimikas are among those who could command significant fees if needed. Edwards' track record suggests that, if they were to leave, Liverpool would secure strong returns. Sustainable Success under Arne Slot There is always a risk with significant player turnover, but Liverpool's meticulous planning minimises it. Each sale is carefully balanced with targeted recruitment, ensuring the squad remains competitive on all fronts. With Edwards guiding the club's transfer dealings and Slot building on last season's title-winning campaign, Liverpool appear well set to remain at the forefront of English football.


Bloomberg
17 minutes ago
- Bloomberg
Poland Shares the Same Equity Problem as the UK
Plans to encourage Polish savers to become domestic investors echo the UK market's woes. By Save Welcome to the award-winning Money Distilled newsletter. I'm John Stepek. Every week day I look at the biggest stories in markets and economics, and explain what it all means for your money. It's been a good year for equities, so far.